- Home
- LCNB vs PROC Comparison
LCNB vs PROC Comparison
Compare LCNB & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- PROC
- Stock Information
- Founded
- LCNB 1877
- PROC 1976
- Country
- LCNB United States
- PROC Luxembourg
- Employees
- LCNB N/A
- PROC N/A
- Industry
- LCNB Major Banks
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- LCNB Finance
- PROC Health Care
- Exchange
- LCNB Nasdaq
- PROC Nasdaq
- Market Cap
- LCNB 212.3M
- PROC 203.1M
- IPO Year
- LCNB N/A
- PROC N/A
- Fundamental
- Price
- LCNB $16.89
- PROC $1.10
- Analyst Decision
- LCNB
- PROC
- Analyst Count
- LCNB 0
- PROC 0
- Target Price
- LCNB N/A
- PROC N/A
- AVG Volume (30 Days)
- LCNB 22.3K
- PROC 68.7K
- Earning Date
- LCNB 10-21-2024
- PROC 11-26-2024
- Dividend Yield
- LCNB 5.13%
- PROC N/A
- EPS Growth
- LCNB N/A
- PROC N/A
- EPS
- LCNB 0.52
- PROC 0.52
- Revenue
- LCNB $74,686,000.00
- PROC $414,096,000.00
- Revenue This Year
- LCNB N/A
- PROC $5.54
- Revenue Next Year
- LCNB $15.49
- PROC $8.54
- P/E Ratio
- LCNB $32.96
- PROC $1.11
- Revenue Growth
- LCNB 3.03
- PROC N/A
- 52 Week Low
- LCNB $12.42
- PROC $0.50
- 52 Week High
- LCNB $17.27
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- LCNB 62.34
- PROC 41.91
- Support Level
- LCNB $16.56
- PROC $0.50
- Resistance Level
- LCNB $17.04
- PROC $1.76
- Average True Range (ATR)
- LCNB 0.34
- PROC 0.18
- MACD
- LCNB -0.01
- PROC -0.06
- Stochastic Oscillator
- LCNB 71.21
- PROC 44.44
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.